GSK Class Action News: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Involving GSK PLCAccesswire • 02/10/25
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm Encourages GSK plc. (GSK) Investors To Inquire About Securities Fraud Class ActionBusiness Wire • 02/10/25
GSK plc Class Action: The Gross Law Firm Reminds GSK Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 7, 2025 - GSKPRNewsWire • 02/10/25
Class Action Filed Against GSK plc (GSK) - April 7, 2025 Deadline to Join – Contact Levi & KorsinskyAccesswire • 02/07/25
Shareholders that lost money on GSK plc (GSK) should contact Levi & Korsinsky about pending Class Action - GSKAccesswire • 02/07/25
GSK PLC Stockholder Notice: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Against GSKGlobeNewsWire • 02/07/25
Securities Fraud Investigation Into GSK plc. (GSK) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law FirmBusiness Wire • 02/06/25
GSK Tech Ecosystem Profile - Digital Transformation Strategies and Innovation ProgramsGlobeNewsWire • 02/06/25
GSK plc. (GSK) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud InvestigationBusiness Wire • 02/05/25
Rosen Law Firm Urges GSK plc (NYSE: GSK) Investors with Large Losses to Contact the Firm for Information About Their RightsBusiness Wire • 02/05/25
Securities Fraud Investigation Into GSK plc. (GSK) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R.Business Wire • 02/05/25
GSK Beats on Q4 Earnings & Sales, Stock Up on Raised Long-Term OutlookZacks Investment Research • 02/05/25
GSK Surges 7% After Bumping Its 2031 Outlook To North Of $50 BillionInvestors Business Daily • 02/05/25
GSK Q4 Earnings: Revenue And EPS Beat, Initiates $2.5 Billion Stock Buyback, Raises Long-Term Annual Sales Forecast To Over $50 BillionBenzinga • 02/05/25
GSK shares rise 5% as it navigates vaccines woes to upgrade sales targetProactive Investors • 02/05/25